Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-25T10:30:27.962Z Has data issue: false hasContentIssue false
  • English
  • Français

African American Suspicion of the Healthcare System Is Justified: What Do We Do about It?

Published online by Cambridge University Press:  29 July 2009

Annette Dula
Annette Dula
Affiliation:
Values and Social Policy, University of Colorado, Boulder
Get access Rights & Permissions [Opens in a new window]

Extract

A recent message on one of the e-mail bulletin boards sent by a college student read, “I believe that the AIDS virus was developed in government labs for the purpose of controlling black folks.” In September 1990, Essence, an African American magazine with a circulation of 900,000, had as a lead article “AIDS: Is It Genocide?” In 1991, the New York Times quoted Clarence Page, African American columnist and Pulitzer prize winner: “You could call conspiracy theories about AIDS and drugs fringe ideas, but they seem, to have a large following among the black intelligentsia. … [And] you find it at all levels.” In April 1992, Lorene Gary explained in Newsweek “Why it's not just paranoia.” In that same month, another New York Times article reported: “Bizarre as it may seem to most people, many black Americans believe that AIDS and the health measures used against it are part of a conspiracy to wipe out the black race.”4 In February 1992, Science quoted Peter Breggin, director of the Center for the Study of Psychiatry in Bethesda, Maryland, as saying that research on violence “cloaks the intention to identify problem black children and then … prescribe pacifying drugs.”

Type
Special Section: Cross-cultural Perspectives in Healthcare Ethics
Information
Cambridge Quarterly of Healthcare Ethics , Volume 3 , Issue 3 , Summer 1994 , pp. 347 - 357
Copyright
Copyright © Cambridge University Press 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Notes

1. Bates, KG. AIDS: is it genocide? Essence 1990; 21(09): 77–116.Google Scholar

2. DeParle, J. For some blacks, social ills seem to follow white plans. New York Times 1991 08. 11: 5.Google Scholar

3. Cary, L. Why it's not just paranoia. Newsweek 1992 04. 6: 23.Google Scholar

4. Anonymous. The AIDS ‘plot’ against blacks. New York Times 1992 05 12: 22.Google Scholar

5. Stone, R. HHS ‘violence initiative’ caught in crossfire. Science 1992; 258: 212.CrossRefGoogle ScholarPubMed

6. Savitt, TL. Medicine and Slavery: The Diseases and Health Care of Blacks in Antebellum Virginia. Chicago: University of Illinois Press, 1978.Google Scholar

7. Abbot, WO. The problem of the professional guinea pig. Proceedings of the Charaka Club 1941; 10: 249–60.Google Scholar

8. Kiple, KF, King, VH. Another Dimension to the Black Diaspora: Diet, Disease, and Racism. Cambridge, England: Cambridge University Press, 1981: 163–74.CrossRefGoogle Scholar

9. Turner, PA. I Heard It through the Grapevine: Rumor in African-American Culture. Berkeley: University of California Press, 1993.Google Scholar

10. Fry, GM. Night Riders in Black Folk History. Knoxville: University of Tennessee Press, 1975.Google Scholar

11. Jones, JH. Bad Blood: The Tuskegee Syphilis Experiment: A Tragedy of Race and Medicine. New York: The Free Press, 1981.Google Scholar

12. Dalton, HL. AIDS in blackface. Daedalus 1989; 118(3): 220.Google Scholar

13. Savitt, TL, Goldberg, MF. Herrick's 1919 case report of sickle cell anemia: the rest of the story. Journal of the American Medical Association 1989; 261: 266–71.CrossRefGoogle Scholar

14. Culliton, BJ. Sickle cell anemia: national program raises problems as well as hopes. Science 1972; 98: 283–6.CrossRefGoogle Scholar

15. Scott, R. Health care priority and sickle cell anemia. Journal of the American Medical Association 1970; 214: 731–4.CrossRefGoogle ScholarPubMed

16. King, PA. The past as prologue: race, class, and gene discrimination. In: Annas, GJ, Elias, S, eds. Gene Mapping: Using Law and Ethics as Guides. New York: Oxford University Press, 1992: 94–111.Google Scholar

17. Bowman, J. Ethical and social issues in screening for genetic disease. New England Journal of Medicine 1972; 287: 204–5.Google Scholar

18. Whitten, C. Sickle-cell programming-an imperiled promise. New England Journal of Medicine 1973; 288: 318–9.CrossRefGoogle ScholarPubMed

19. Rutkow, IM, Upton, JM. Some negative aspects of state health departments' policies related to screening for sickle cell anemia. American Journal of Public Health 1974; 64: 217–21.CrossRefGoogle ScholarPubMed

20. Jones, S, Binder, R, Donowho, E. Sudden death in sickle-cell trait. New England Journal of Medicine 1970; 282: 323–5.CrossRefGoogle ScholarPubMed

21. Letters to the Editor. Sickle cell trait. New England Journal of Medicine 1970; 282: 1157–8.CrossRefGoogle Scholar

22. Bowman, J. Ethical, legal, and humanistic implications of sickle cell programs. Inserm 1975; 44: 353–78.Google Scholar

23. Murray, RF. Public health perspectives on screening and problems in counseling in sickle cell anemia. In: Cohen, B, Lilienfield, A, Glass, B, eds. Genetic Issues in Public Health and Medicine. Springfield, Illinois: Charles C Thomas, 1978: 264–79.Google Scholar

24. Grossman, LK, Holtzman, N, Charney, E, Schwartz, AD. Neonatal screening and genetic counseling for sickle cell trait. American Journal of Disabled Child 1985; 139: 241–4.Google ScholarPubMed

25. Mass, B. Population Target: The Political Economy of Population Control in Latin America. Toronto: Women's Press, 1976.Google Scholar

26. Gordon, L. Woman's Body, Woman's Right: Birth Control in America. 2nd ed.New York: Penguin, 1975.Google Scholar

27. Rodriguez-Trias, H. Sterilization abuse. In: Hubbard, R, Henifin, MS, Fried, B, eds. Biological Woman - The Convenient Myth: A Collection of Feminist Essays and a Comprehensive Bibliography. Cambridge, Massachusetts: Schenkman, 1982: 147–60.Google Scholar

28. Petchesky, RP. Reproduction, ethics, and public policy: the federal sterilization regulations. Hastings Center Report 1979; 5: 29–41.CrossRefGoogle Scholar

29. Aptheker, H. Sterilization, experimentation and imperialism. Political Affairs 1974; 53: 37–48.Google ScholarPubMed

30. Reilly, PR. The Surgical Solution: A History of Involuntary Sterilization in the United States. Baltimore, Maryland: Johns Hopkins University Press, 1991.Google Scholar

31. Thomas, SB, Quinn, SC. The AIDS epidemic and the African-American community: toward a new ethical framework for service delivery. In: Dula, A, Goering, S, eds. “It Just Ain't Fair!” The Ethics of Health Care for African Americans. Westport, Connecticut: Greenwood (in press).Google Scholar

32. Horgan, J. Eugenics revisited. Scientific American 1993; 268: 122–31.CrossRefGoogle ScholarPubMed

33. Bass, A. Controversy places research in peril. The Boston Globe 1993 02. 2: 37.Google Scholar

34. Saltus, R. Evidence that genes play a role in violence is weak. The Boston Globe 1993 02. 2: 37.Google Scholar

35. Marshall, E. NIH told to reconsider crime meeting. Science 1993; 262: 24.CrossRefGoogle ScholarPubMed

36. Morell, V. Evidence found for a possible “aggression gene.” Science 1993; 260: 1722–3.CrossRefGoogle Scholar

37. Centers for Disease Control. Infant mortality - United States, 1991. Morbidity and Mortality Weekly Report 1993; 42(48): 926–30.Google Scholar

38. Centers for Disease Control. Surveillance for diabetes mellitus-United States, 1980–1989. Morbidity and Mortality Weekly Report 1993; 42(SS–2): 1–20.Google Scholar

39. Centers for Disease Control. Tuberculosis morbidity - United States, 1992. Morbidity and Mortality Weekly Report 1993; 42(36): 696.Google Scholar

40. Baquet, CR, Gibbs, T. Cancer and black Americans. In: Braithwaite, RL, Taylor, SE, eds. Health Issues in the Black Community. San Francisco: Jossey-Bass, 1992: 106–2.Google Scholar

41. Centers for Disease Control. Update: mortality attributable to HIV infection/AIDS among persons aged 25–44 years -United States, 1990 and 1991. Morbidity and Mortality Weekly Report 1993; 42(25):481–6.Google Scholar

42. Hildreth, CJ, Saunders, E. Heart disease, stroke, and hypertension in blacks. In: Braithwaite, RL, Taylor, SE, eds. Health Issues in the Black Community. San Francisco: Jossey-Bass, 1992: 90–105.Google Scholar

43. Hale, CB. A demographic profile of African Americans. In: Braithwaite, RL, Taylor, SE, eds. Health Issues in the Black Community. San Francisco: Jossey-Bass, 1992: 6–19.Google Scholar

44. Escarce, JJ, Epstein, KR, Colby, DC, Schwartz, JS. Racial differences in the elderly's use of medical procedures and diagnostic tests. American Journal of Public Health 1993; 83(7): 948–54.CrossRefGoogle ScholarPubMed

45. Whittle, J, Conigliaro, J, Good, CB, Lofgren, RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. New England Journal of Medicine 1993; 329: 621–7.CrossRefGoogle ScholarPubMed

46. Gaston, RS, Ayres, I, Dooley, LG, Diethelm, AG. Racial equality in renal transplantation: the disparate impact of HLA-based allocation. Journal of the American Medical Association 1993; 270: 1353.Google Scholar

47. Caralis, PV, Davis, B, Wright, K, Marcial, E. The influence of ethnicity and race on attitudes toward advance directives, life-prolonging treatments, and euthanasia. The Journal of Clinical Ethics 1993; 4(2): 155–6.Google ScholarPubMed

48. Pappas, G, Queen, S, Hadden, W, Fisher, G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. New England Journal of Medicine 1993; 329: 103–9.CrossRefGoogle ScholarPubMed

49. Anderson, W. The New York needle trial: the politics of public health in the age of AIDS. American Journal of Public Health 1991; 81: 1512.CrossRefGoogle Scholar

50. Gemson, DH, Elinson, J, Messeri, P. Differences in physician prevention practices for white and minority patients. Journal of Community Health 1988; 13: 53–64.CrossRefGoogle Scholar

51. Ayanian, JZ. Heart disease in black and white. New England Journal of Medicine 1993; 329: 656–7.CrossRefGoogle ScholarPubMed

52. Svensson, CK. Representation of American blacks in clinical trials of new drugs. Journal of the American Medical Association 1989; 261: 263–5.CrossRefGoogle ScholarPubMed

53. El-Sadr, W, Capps, L. The challenge of minority recruitment in clinical trials for AIDS. Journal of the American Medical Association 1992; 267: 954–7.CrossRefGoogle Scholar

54. Morsy, MA, Mitani, K, Clemens, P, Caskey, T. Progress toward human gene therapy. Journal of the American Medical Association 1993; 270: 2338–45.CrossRefGoogle ScholarPubMed

55. Annas, GJ. Privacy rules for DNA databanks: protecting coded “future diaries.” Journal of the American Medical Association 1993; 270: 2346–50.CrossRefGoogle Scholar

56. Bowman, J. Genetic screening: toward a new eugenic. In: Dula, A, Goering, S, eds. “It Just Ain't Fair!” The Ethics of Health Care for African Americans. Westport, Connecticut: Greenwood (in press).Google Scholar

57. Rosenberg, ML, O'Carroll, PW, Powell, KE. Let's be clear: violence is a public health problem. Journal of the American Medical Association 1992; 267: 3073.Google ScholarPubMed

58. Mason, JO, McGinnis, JM. “Healthy People 2000”: an overview of the national health promotion and disease prevention objectives. Public Health Reports 1990; 105: 441–6.Google ScholarPubMed

59. Centers for Disease Control. Use of race and ethnicity in public health surveillance: summary of the CDC/ATSDR Workshop. Morbidity and Mortality Weekly Report 1993; 42(RR–10): 1–17.Google Scholar